Spanish Red Biotech Pipeline

CIBER

Gene editing medicinal product for Epidermolysis Bullosa

Type: Gene / Cell Therapy
Therapeutic area:
Indication: Epidermolysis Bullosa. Autologous skin equivalent graft composed of keratinocytes and fibroblasts genetically corrected by Crispr/Cas9-mediated
Phase: 2Regulatory Preclinical, 1Non Regulatory Preclinical